After it was approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.

A battle has been brewing between President Trump and the judicial system as courts delay some of the administration's rapid fire executive orders. WSJ’s Jess Bravin joins Ryan Knutson and Molly Ball to discuss the recent clashes between Trump and the courts. 

Greenland could satisfy the world’s hunger for minerals, if miners could just start digging. WSJ’s Sune Rasmussen explains why Greenland’s minerals remain mostly untapped, and what bringing these rare earths to the surface could mean to the global supply chain.